Quickly ID and track dangerous antibiotic-resistant infections through hospitals and networks.
Patients colonized or infected with AMR organisms are often cared for in multiple settings, ranging from emergency departments to nursing facilities. As these patients move from place to place, they bring the AMR organisms with them, spreading them between facilities. For that reason, it’s essential for all parts of a healthcare system to know immediately when AMR organisms are detected.
Acuitas Lighthouse is a powerful tool for network-wide surveillance of AMR organisms. All stakeholders in a hospital or network can share data through the Acuitas Lighthouse interface, see threats around them in real time, and avoid outbreaks by knowing infection patterns in advance.
Acuitas Lighthouse Profiles are created instantly using pathogen identity and detected resistance genes. Identical profiles indicate that strains may be related and signal a possible transmission event.
A past OpGen partnership successfully tracked antimicrobial resistance in Washington, DC and now OpGen is working with New York State, developing a state-of-the art research program to detect, track, and manage antimicrobial resistant infections at healthcare institutions statewide.
This partnership (HARP-DC Study), funded by the CDC, tracked cases of CRE in 16 facilities ranging from acute care to skilled nursing homes. After screening nearly 1000 patients, OpGen was able to establish a baseline of CRE prevalence in the region (5.2%) and Acuitas Lighthouse instantly signalled a transmission event in one facility which was later confirmed by Whole Genome Sequencing.
- Washington DC Department of Health
- DC Department of Forensic Science-Public Health Laboratory
- DC Hospital Association
With its collaborating partners, OpGen is developing a digital health and precision medicine platform that links the NY Department of Health with healthcare institutions statewide. The system will aid in surveillance and control of antibiotic-resistant microbes, using Acuitas Lighthouse and Acuitas AMR Gene Panel as core technology.
- NY State Department of Health
- ILÚM Health Solutions (Merck)
For Research Use Only. Not for use in diagnostic procedures.